Concise review: Animal substance-free human embryonic stem cells aiming at clinical applications

Stem Cells Translational Medicine

Volumn 3, Issue 11, 2014, Pages 1269-1274

  Hovatta, Outi ^a   Rodin, Sergey ^b   Antonsson, Liselotte ^a   Tryggvason, Karl ^b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Clinical translation; Embryonic stem cells; Pluripotent stem cells; Serum free; Stem cell culture

Indexed keywords

MATRIGEL; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

AGE RELATED MACULAR DEGENERATION; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; FEEDER CELL; FETAL STEM CELL; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC STABILITY; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFECTION; INNER CELL MASS; OLIGODENDROGLIA; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD INJURY; ANIMAL; CYTOLOGY; HISTORY; MACULAR DEGENERATION; METABOLISM; PROCEDURES; REGENERATIVE MEDICINE; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION;

ANIMALIA;

ANIMALS; EMBRYONIC STEM CELLS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MACULAR DEGENERATION; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION;

EID: 84908375391     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0129     Document Type: Article

References (54)

1. Fishel SB, Edwards RG, Evans CJ. Human chorionic gonadotropin secreted by preimplantation embryos cultured in vitro. Science 1984; 223:816-818.
2. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282: 1145-1147.
3. Reubinoff BE, Pera MF, Fong CY, et al. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat Biotechnol 2000;18:399-404.
4. Rodin S, Antonsson L, Niaudet C, et al. Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin matrix in defined and xeno-free environment. Nat Commun 2014;5:3195.
5. Hovatta O, Mikkola M, Gertow K, et al. A culture system usinghumanforeskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum Reprod 2003;18: 1404-1409.
6. Koivisto H, Hyvärinen M, Strömberg AM, et al. Cultures of human embryonic stem cells: Serum replacement medium or serumcontaining media and the effect of basic fibroblast growth factor. Reprod Biomed Online 2004;9:330-337.
7. Inzunza J, Gertow K, Strömberg MA, et al. Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. STEM CELLS 2005;23:544-549.
8. Ström S, Rodriguez-Wallberg K, Holm F, et al. No relationship between embryo morphology and successful derivation of human embryonic stem cell lines. PLoS One 2010;5: e15329.
9. Xu C, Inokuma MS, Denham J, et al. Feederfree growth of undifferentiated human embryonic stem cells. Nat Biotechnol 2001;19:971-974.
10. Carpenter MK, Rosler E, Rao MS. Characterization and differentiation of human embryonic stem cells. Cloning Stem Cells 2003;5: 79-88.
11. Kleinman HK, Martin GR. Matrigel: Basement membrane matrix with biological activity. Semin Cancer Biol 2005;15:378-386.
12. Akopian V, Andrews PW, Beil S, et al. Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. In Vitro Cell Dev Biol Anim 2010;46: 247-258.
13. Unger C, Skottman H, Blomberg P, et al. Good manufacturing practice and clinicalgrade human embryonic stem cell lines. Hum Mol Genet 2008;17:R48-R53.
14. Ilic D, Giritharan G, Zdravkovic T, et al. Derivation of human embryonic stem cell lines from biopsied blastomeres on human feeders with minimal exposure to xenomaterials. Stem Cells Dev 2009;18:1343-1350.
15. Ludwig TE, Levenstein ME, Jones JM, et al. Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 2006;24: 185-187.
16. Crook JM, Peura TT, Kravets L, et al. The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell 2007; 1:490-494.
17. Tannenbaum SE, Turetsky TT, Singer O, et al. Derivation of xeno-free and GMP-grade human embryonic stem cells—platforms for future clinical applications. PLoS One 2012;7: e35325.
18. Rodin S, Domogatskaya A, Ström S, et al. Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat Biotechnol 2010;28:611-615.
19. Klaffky E, Williams R, Yao CC, et al. Trophoblast-specific expression and function of the integrin alpha 7 subunit in the periimplantation mouse embryo. Dev Biol 2001;239: 161-175.
20. Doi M, Thyboll J, Kortesmaa J, et al. Recombinant human laminin-10 (alpha5beta1-gamma1). Production, purification, andmigrationpromoting activity on vascular endothelial cells. J Biol Chem 2002;277:12741-12748.
21. Melkoumian Z, Weber JL, Weber DM, et al. Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol 2010;28:606-610.
22. Villa-Diaz LG, Nandivada H, Ding J, et al. Synthetic polymer coatings for long-term growth ofhumanembryonic stem cells. Nat Biotechnol 2010;28:581-583.
23. Domogatskaya A, Rodin S, Tryggvason K. Functional diversity of laminins. Annu Rev Cell Dev Biol 2012;28:523-553.
24. Klimanskaya I, Chung Y, Becker S, et al. Human embryonic stem cell lines derived from single blastomeres. Nature 2006;444:481-485.
25. Taylor CJ, Bolton EM, Pocock S, et al. Banking on human embryonic stem cells: Estimating the number of donor cell lines needed for HLA matching. Lancet 2005;366:2019-2025.
26. Daughtry B, Mitalipov S. Concise review: Parthenote stem cells for regenerative medicine: Genetic, epigenetic, and developmental features. STEM CELLS TRANSLATIONAL MEDICINE 2014;3:290-298.
27. Murdoch A, Braude P, Courtney A, et al. The procurement of cells for the derivation of human embryonic stem cell lines for therapeutic use: Recommendations for good practice. Stem Cell Rev 2012;8:91-99.
28. Jacquet L, Stephenson E, Collins R, et al. Strategy for the creation of clinical grade hESC line banks that HLA-match a target population. EMBO Mol Med 2013;5:10-17.
29. Zhao T, Zhang ZN, Rong Z, et al. Immunogenicity of induced pluripotent stem cells. Nature 2011;474:212-215.
30. Ma H, Morey R, O’Neil RC, et al. Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature 2014; 511:177-183.
31. Bhattacharya B, Cai J, Luo Y, et al. Comparison of the gene expression profile of undifferentiated human embryonic stem cell lines and differentiating embryoid bodies. BMC Dev Biol 2005;5:22.
32. Vallier L, Reynolds D, Pedersen RA. Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev Biol 2004;275:403-421.
33. Silva J, Smith A. Capturing pluripotency. Cell 2008;132:532-536.
34. Närvä E, Autio R, Rahkonen N, et al. Highresolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol 2010;28:371-377.
35. Amps K, Andrews PW, Anyfantis G, et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol 2011;29:1132-1144.
36. Adewumi O, Aflatoonian B, Ahrlund-Richter L, et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007;25: 803-816.
37. Hovatta O, Jaconi M, Töhönen V, et al. A teratocarcinoma-like human embryonic stem cell (hESC) line and four hESC lines reveal potentially oncogenic genomic changes. PLoS One 2010;5:e10263.
38. Jacobs K, Mertzanidou A, Geens M, et al. Low-grade chromosomal mosaicism in human somatic and embryonic stem cell populations. Nat Commun 2014;5:4227.
39. Bibikova M, Laurent LC, Ren B, et al. Unraveling epigenetic regulation in embryonic stem cells. Cell Stem Cell 2008;2:123-134.
40. Cerdan C, Hong SH, Bhatia M. Formation and hematopoietic differentiation of human embryoid bodies by suspension and hanging drop cultures. Curr Protoc Stem Cell Biol. 2007; Chapter 1Unit 1D2.
41. Nat R, Nilbratt M, Narkilahti S, et al. Neurogenic neuroepithelial and radial glial cells generated from six human embryonic stem cell lines in serum-free suspension and adherent cultures. Glia 2007;55:385-399.
42. Cai J, Zhao Y, Liu Y, et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 2007;45: 1229-1239.
43. Qu C, Puttonen KA, Lindeberg H, et al. Chondrogenic differentiation of human pluripotent stem cells in chondrocyte coculture. Int J Biochem Cell Biol 2013;45:1802-1812.
44. Lee AS, Tang C, Rao MS, et al. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med 2013;19: 998-1004.
45. Draper JS, Smith K, Gokhale P, et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 2004;22:53-54.
46. Choo AB, Tan HL, Ang SN, et al. Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. STEM CELLS 2008; 26:1454-1463.
47. Tang C, Lee AS, Volkmer JP, et al. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat Biotechnol 2011; 29:829-834.
48. Ben-David U, Gan QF, Golan-Lev T, et al. Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. Cell Stem Cell 2013;12:167-179.
49. Di Stasi A, Tey SK, Dotti G, et al. Inducible apoptosis as a safety switch for adoptive cell therapy. N Engl J Med 2011;365:1673-1683.
50. Hovatta O, Stojkovic M, Nogueira M, et al. European scientific, ethical, and legal issues on human stem cell research and regenerative medicine. STEM CELLS 2010;28:1005-1007.
51. http://www.clinicaltrials.gov/.Clinical trials. Available at http://www.clinicaltrials. gov/.
52. Piltti KM, Salazar DL, Uchida N, et al. Safety of human neural stem cell transplantation in chronic spinal cord injury. STEM CELLS TRANSLATIONAL MEDICINE 2013;2:961-974.
53. Schwartz SD, Hubschman JP, Heilwell G., et al. Embryonicstemcelltrialsformaculardegeneration: A preliminary report. Lancet 2012;379:713-720.
54. Seiger A. Collection and use of fetal central nervous system tissue. Fetal Ther 1989;4 (suppl 1):104-107.